Back to Test Catalogue

Flecainide, Serum/Plasma

Test ID: FLECA S

Test

Aliases/Synonyms

Tambocor®

Method

Chromatography/Mass Spectrometry

Report Includes

Flecainide

Specimens

Avoid gel separator tubes; Serum; Plasma (EDTA)

Clinical Utility

Monitoring the Flecainide concentration is used to assure compliance and avoid toxicity of this cardiac drug used to treat ventricular tachycardia and premature contractions.

Test Location

Quest Diagnostics, California USA

Test Version

8-Sep-2023

Specimen

Specimens

Avoid gel separator tubes; Serum; Plasma (EDTA)

Sample Volume

2.0 mL

Minimum Volume

0.5 mL

Specimen Comment

Avoid gel separator tubes.

Collection & Handling

Collection Instructions

Collect trough specimen within 1 hour prior to next dose.

Handling Information

Store and send frozen.

Stability

Ambient 5 days
Refrigerated 7 days
Frozen 30 days

Rejection Criteria

Specimen Gel-separator tube
Hemolysis Gross
Lipemia Present

Test Version

8-Sep-2023

Performance / Interpretation

Method

Chromatography/Mass Spectrometry

Turnaround Time

11 days

Results

Name Units Reference Range Conversion Factor
Flecainide mcg/mL
  • 0.20 - 0.99

Test Location

Quest Diagnostics, California USA

Test Version

8-Sep-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
FLECA S 63100FLECAINIDE mcg/mL

Test Version

8-Sep-2023